| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Training > The KYSS Principle - Keep Your Sales Simple, Your Sales Closes Will Explode |
|
Digg It - The KYSS Principle - Keep Your Sales Simple, Your Sales Closes Will Explode
The simpler you make the decision making steps for your prospects the higher your sales close ratio will go. When there are too many decisions people will procrastinate.
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product me.
KYSS—Keep Your Sales Simple The more choices you give someone the lower the positive response rate to your marketing efforts and sales close attempts. For instanc ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in , in my direct mail if I ask the prospect to either go to my website or give me a call. That is two options. The response rate is lower than if I just ask them to call. What happens is that you’ve put one more decision between you and them. First they have to decide that they will contact you, but th lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. en they’ve got to decide which way they will use. Sounds simple doesn’t it. You’d think it would be anyway. But you just put one more step between you and them, one more decision that just might not be done right away, or put on the procrastination path. Make it simple and watch the response rate go u here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe . Ask them to do only one thing. When you ask for more than one decision at a time you increase the probability that a decision won’t be made. You’ve put one more obstacle in the path, and your goal should be to make it as easy as possible to buy. Remove all obstacles. I have a client that had been d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro very successful, up until he increased the number of items he sells. At the time he was doing a presentation that was so powerful that every prospect was wowed and just about everyone in the room decided to stop using every competitor’s product by the time he had finished. At the time he gave them one ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc product and they bought. But he had a huge line, so he decided to start giving them a catalog right after the presentation. After all, he thought, now that they’ve got a greater choice they are more likely to find a product that would be a match for everyone and he expected his sales to increase. No easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t only were there a LOT of different packages in the catalog, each package increased in complexity and price until you almost couldn’t tell what was in the package from the picture for the clutter of pieces. It was a chaotic picture of so many choices. His sales plummeted and he couldn’t understand i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically . He was looking for every other possibility except at the complexity of the sale he just created. After the presentation, the husband and wife prospects usually had decided to buy, but they spent the rest of the evening arguing over which product they’d buy, and usually walked away saying, “We’ll th and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ink it over. We’ll get back to you after we’ve made our decision.” Usually no decision was forthcoming. There were too many choices.
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi that, therefore they could see a reason to go with almost any package. Normally that would result in indecision . . . in other words no decision.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a I can afford doesn’t have what I want. Too many choices, too many obstacles There are too many obstacles to making a decision. Too many obstacles between you and your prospect’s decision. Change that. Make it easy to make a decision. In this case, they had already decided to buy. Get tha dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod commitment by taking them through the decision steps. Don’t assume that they will come to the conclusion when there are so many options. It won’t happen. Guide them to the answer through a logical step by step process.
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin g of a problem do you think it really is? [establish a value]
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen And even better is to turn these questions into open ended questions where the prospect is discovering the answers himself. For this client I asked him to define his two best selling items, and to put only those two on the handout he gives prospects at the en t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel d of his presentation. He asked me what he’d do with the rest of the line. Here’s what I suggested.
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust lly price becomes an issue
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products resolve [their problem]? Then you reveal the OTHER products that they can afford. You’ve already gotten a commitment they want your product. Then they moved to price, so help them get it at their price and you’ve got a sale. If they want . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de his item or that item that may not be in either package, then show them the next package up in price that has the items they want. They have only one decision to make and you are up selling them one step at a time, not confusing them with pages of products. KYSS—Keep your sales simple Re elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip duce sales decision to the simplest, most linear steps to the close that you can.
Your sales closes will go through the roof tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Tips in Raising Funds for a Good Cause Trade Show Models for Your Next Convention or Expo
|